BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33461003)

  • 1. Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes.
    Bandara WMMS; Rathnayake AJIS; Neththikumara NF; Goonasekera HWW; Dissanayake VHW
    Blood Cells Mol Dis; 2021 May; 88():102535. PubMed ID: 33461003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Novel Insertions and Deletions in Haematopoietic Stem/Progenitor Cells in de novo Myelodysplastic Syndromes.
    Bandara M; Goonasekera H; Dissanayake V
    Int J Mol Cell Med; 2021; 10(3):228-233. PubMed ID: 35178361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β-catenin signalling by parallel RNA sequencing and dysfunctional phenotypes.
    Xu R; Huang X; Li C; Deng C; Li M; Wu P; Geng S; Lai P; Lu Z; Weng J; Du X
    Br J Haematol; 2021 Jun; 193(5):928-940. PubMed ID: 33959953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FAK Deficiency in Bone Marrow Stromal Cells Alters Their Homeostasis and Drives Abnormal Proliferation and Differentiation of Haematopoietic Stem Cells.
    Wu Y; Campos L; Daguenet E; He Z; Picot T; Tavernier-Tardy E; Soglu G; Guyotat D; Aanei CM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32155953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
    Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A
    Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes.
    Xing T; Lyu ZS; Duan CW; Zhao HY; Tang SQ; Wen Q; Zhang YY; Lv M; Wang Y; Xu LP; Zhang XH; Huang XJ; Kong Y
    J Transl Med; 2022 Mar; 20(1):144. PubMed ID: 35351133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo.
    Jann JC; Mossner M; Riabov V; Altrock E; Schmitt N; Flach J; Xu Q; Nowak V; Obländer J; Palme I; Weimer N; Streuer A; Jawhar A; Darwich A; Jawhar M; Metzgeroth G; Nolte F; Hofmann WK; Nowak D
    Nat Commun; 2021 Oct; 12(1):6170. PubMed ID: 34697318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow.
    Flores-Figueroa E; Varma S; Montgomery K; Greenberg PL; Gratzinger D
    Lab Invest; 2012 Sep; 92(9):1330-41. PubMed ID: 22710983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity.
    Wu L; Amarachintha S; Xu J; Oley F; Du W
    Br J Haematol; 2018 Nov; 183(3):445-456. PubMed ID: 30106181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells.
    Wobus M; Mies A; Asokan N; Oelschlägel U; Möbus K; Winter S; Cross M; Weidner H; Rauner M; Hofbauer LC; Bornhäuser M; Platzbecker U
    Leukemia; 2021 Oct; 35(10):2936-2947. PubMed ID: 34002031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
    Azuma K; Umezu T; Imanishi S; Asano M; Yoshizawa S; Katagiri S; Ohyashiki K; Ohyashiki JH
    Leuk Res; 2017 Nov; 62():23-28. PubMed ID: 28964959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
    Mattiucci D; Maurizi G; Leoni P; Poloni A
    Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.
    Hua Y; Wang C; Jiang H; Wang Y; Liu C; Li L; Liu H; Shao Z; Fu R
    Int J Hematol; 2017 Aug; 106(2):248-257. PubMed ID: 28405919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic Syndromes and Metabolism.
    Balaian E; Wobus M; Bornhäuser M; Chavakis T; Sockel K
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 Function.
    Sun J; He X; Zhu Y; Ding Z; Dong H; Feng Y; Du J; Wang H; Wu X; Zhang L; Yu X; Lin A; McDonald T; Zhao D; Wu H; Hua WK; Zhang B; Feng L; Tohyama K; Bhatia R; Oberdoerffer P; Chung YJ; Aplan PD; Boultwood J; Pellagatti A; Khaled S; Kortylewski M; Pichiorri F; Kuo YH; Carlesso N; Marcucci G; Jin H; Li L
    Cell Stem Cell; 2018 Sep; 23(3):355-369.e9. PubMed ID: 30146412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution.
    Ainciburu M; Ezponda T; Berastegui N; Alfonso-Pierola A; Vilas-Zornoza A; San Martin-Uriz P; Alignani D; Lamo-Espinosa J; San-Julian M; Jiménez-Solas T; Lopez F; Muntion S; Sanchez-Guijo F; Molero A; Montoro J; Serrano G; Diaz-Mazkiaran A; Lasaga M; Gomez-Cabrero D; Diez-Campelo M; Valcarcel D; Hernaez M; Romero JP; Prosper F
    Elife; 2023 Jan; 12():. PubMed ID: 36629404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors.
    Sinha S; Chatterjee SS; Biswas M; Nag A; Banerjee D; De R; Sengupta A
    Exp Hematol; 2018 Jun; 62():39-44.e2. PubMed ID: 29596882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of myelodysplastic syndromes (MDS): An update.
    Ganguly BB; Kadam NN
    Mutat Res Rev Mutat Res; 2016; 769():47-62. PubMed ID: 27543316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
    Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
    Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.